MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$2.20−0.09 (-3.93%)

Close on Nov 13, 2026Market cap $140.14MP/E –Yield –

MacroGenics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

MacroGenics's EV/EBITDA was 654.4× on Oct 31, 2014.

Period	Period end	Value	Change (pts)
2014	Oct 31, 2014	654.4×	+635.6
2013	Dec 31, 2013	18.8×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MGNX.

Revenue growth67.6% · median 23.3%

Operating margin-41.5% · median -61.2%

Net margin-33.2% · median -58.8%

Advertisement
300 × 250

See a number that looks wrong?